X
CNMD icon

Xponance’s CONMED CNMD Stock Holding History

Xponance’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,862
Closed -$204K – 1315
2023
Q4 		$204K Buy
+1,862
New +$193K ﹤0.01% 1157
2023
Q3 		– Sell
-1,800
Closed -$245K – 1249
2023
Q2 		$245K Buy
+1,800
New +$220K ﹤0.01% 1098
2022
Q2 		– Sell
-1,844
Closed -$273K – 1200
2022
Q1 		$273K Buy
+1,844
New +$257K ﹤0.01% 1043
2021
Q3 		– Sell
-2,051
Closed -$282K – 1194
2021
Q2 		$282K Buy
+2,051
New +$281K 0.01% 1088

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.3B AUM 29.38% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Xponance's CNMD Position: Q1 2024 in Review

Xponance sold out of CONMED (CNMD) in Q1 2024, closing a stake of 1,862 shares — an estimated $204K sold.

Xponance first reported a position in CNMD in Q2 2021 and held it in 4 quarters. The position peaked at $282K in Q2 2021. 298 funds tracked by Wall St. Rank hold CNMD as of Q1 2024.

  • Xponance reported no remaining CONMED position as of Q1 2024 after selling out during the quarter.
  • Xponance sold 1,862 CONMED shares in Q1 2024, an estimated $204K.
  • Xponance first reported a position in CONMED in Q2 2021 and held it in 4 quarters.
  • Xponance's CONMED position peaked at $282K in Q2 2021.
  • 298 funds tracked by Wall St. Rank held CONMED as of Q1 2024.

Based on Xponance's 13F filing for Q1 2024, filed 13 May 2024.